Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | May 07, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date May 07, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
After 2026-05-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-07 · Grant · Acquired 7,500 · Balance 7,500 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Shares of Common StockSEC Table I · non-derivative | Direct | 43,302 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 43,302 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 4,360 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,360 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 5,508 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,508 Underlying: Common Stock · 5,508 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 5,508 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 4 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,508 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 3,418 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,418 Underlying: Common Stock · 3,418 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 21:51 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 3,418 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020599 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,418 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to four outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 13:43 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $52.93 | $0.00 |
DisclosureSEC source: 0001437749-18-012043 · rdgdoc.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 13:43 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 5,599 | $70.89 | $396,913.11 |
DisclosureSEC source: 0001437749-18-012043 · rdgdoc.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,920 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 13:43 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $52.93 | $396,975.00 |
DisclosureSEC source: 0001437749-18-012043 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 8, 2014. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 14, 2018 Filed Jun 14, 2018 19:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 2,308 | $69.49 | $160,382.92 |
DisclosureSEC source: 0001437749-18-011811 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,019 Read SEC document |
| May 03, 2018 Filed May 4, 2018 15:06 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-18-008625 · rdgdoc.xml · derivative · entry 6 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 19:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,041 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-18-002847 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,418 Underlying: Common Stock · 5,459 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 19:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 2,041 | $61.25 | $125,011.25 |
DisclosureSEC source: 0001437749-18-002847 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 16, 2017 Filed Nov 16, 2017 20:07 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,192 | $65.00 | $77,480.00 |
DisclosureSEC source: 0001437749-17-019506 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,286 Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 17:09 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 800 | $64.00 | $51,200.00 |
DisclosureSEC source: 0001437749-17-019497 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,478 Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 19:41 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 800 | $64.00 | $51,200.00 |
DisclosureSEC source: 0001437749-17-019504 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,478 F1 · date: 4/A filed to amend transaction date. No other changes. Read SEC document |
| May 09, 2017 Filed May 10, 2017 17:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001047335-17-000098 · edgar.xml · derivative · entry 5 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 19:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,992 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001047335-17-000056 · edgar.xml · derivative · entry 4 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,508 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 19:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,992 | $62.78 | $125,057.76 |
DisclosureSEC source: 0001047335-17-000056 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on June 2, 2016. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 06, 2017 Filed Apr 21, 2017 15:19 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,992 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001047335-17-000086 · edgar.xml · derivative · entry 4 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,508 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Apr 21, 2017 15:19 UTC Amendment | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 1,992 | $62.78 | $125,057.76 |
DisclosureSEC source: 0001047335-17-000086 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This transaction was reported correctly on the original Form 4. The reason for this amendment is to correct the total amount owned following the transaction, which was incorrect in the original Form 4. Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 21:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 879 | $70.49 | $61,960.71 |
DisclosureSEC source: 0001047335-16-000274 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,286 Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 15:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,000 | $70.00 | $70,000.00 |
DisclosureSEC source: 0001047335-16-000272 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,165 Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 14:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleShares of Common Stock | 1,000 | $69.44 | $69,440.00 |
DisclosureSEC source: 0001047335-16-000270 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,165 Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:00 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $47.75 | $0.00 |
DisclosureSEC source: 0001047335-16-000267 · edgar.xml · derivative · entry 3 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:00 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 5,192 | $68.53 | $355,807.76 |
DisclosureSEC source: 0001047335-16-000267 · edgar.xml · nonDerivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,165 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total number of shares after this transaction. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:00 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 7,500 | $47.45 | $355,875.00 |
DisclosureSEC source: 0001047335-16-000267 · edgar.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.